Northern Trust’s Kindred Biosciences, Inc. KIN Stock Holding History

Northern Trust’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-97,490	Closed	-$894K	–	4794
2021 Q2	$894K	Sell	97,490 -299,367	-75%	-$2.75M	﹤0.01%	3552
2021 Q1	$1.97M	Sell	396,857 -54,886	-12%	-$273K	﹤0.01%	3249
2020 Q4	$1.95M	Sell	451,743 -5,435	-1%	-$23.4K	﹤0.01%	3214
2020 Q3	$1.96M	Sell	457,178 -22,032	-5%	-$94.5K	﹤0.01%	3071
2020 Q2	$2.15M	Buy	479,210 +13,239	+3%	+$59.5K	﹤0.01%	3016
2020 Q1	$1.86M	Buy	465,971 +20,225	+5%	+$80.9K	﹤0.01%	2895
2019 Q4	$3.78M	Sell	445,746 -8,084	-2%	-$68.6K	﹤0.01%	2759
2019 Q3	$3.11M	Buy	453,830 +23,129	+5%	+$158K	﹤0.01%	2842
2019 Q2	$3.59M	Buy	430,701 +8,583	+2%	+$71.5K	﹤0.01%	2738
2019 Q1	$3.87M	Buy	422,118 +49,549	+13%	+$454K	﹤0.01%	2703
2018 Q4	$4.08M	Sell	372,569 -8,527	-2%	-$93.4K	﹤0.01%	2627
2018 Q3	$5.32M	Buy	381,096 +92,709	+32%	+$1.29M	﹤0.01%	2653
2018 Q2	$3.07M	Buy	288,387 +22,770	+9%	+$242K	﹤0.01%	2969
2018 Q1	$2.3M	Buy	265,617 +3,457	+1%	+$29.9K	﹤0.01%	3031
2017 Q4	$2.48M	Buy	262,160 +23,186	+10%	+$219K	﹤0.01%	3020
2017 Q3	$1.88M	Buy	238,974 +25,707	+12%	+$202K	﹤0.01%	3222
2017 Q2	$1.83M	Buy	213,267 +184,770	+648%	+$1.59M	﹤0.01%	3215
2017 Q1	$201K	Buy	28,497 +2,698	+10%	+$19K	﹤0.01%	3795
2016 Q4	$110K	Buy	25,799 +374	+1%	+$1.6K	﹤0.01%	3879
2016 Q3	$127K	Sell	25,425 -70	-0.3%	-$350	﹤0.01%	3848
2016 Q2	$90K	Buy	25,495 +8,056	+46%	+$28.4K	﹤0.01%	3918
2016 Q1	$60K	Hold	17,439	–	–	﹤0.01%	3999
2015 Q4	$59K	Hold	17,439	–	–	﹤0.01%	4031
2015 Q3	$91K	Sell	17,439 -80,880	-82%	-$422K	﹤0.01%	3953
2015 Q2	$671K	Sell	98,319 -13,171	-12%	-$89.9K	﹤0.01%	3479
2015 Q1	$797K	Sell	111,490 -1,130	-1%	-$8.08K	﹤0.01%	3471
2014 Q4	$839K	Sell	112,620 -1,885	-2%	-$14K	﹤0.01%	3436
2014 Q3	$1.06M	Buy	114,505 +4,439	+4%	+$41.1K	﹤0.01%	3403
2014 Q2	$2.05M	Buy	110,066 +79,615	+261%	+$1.48M	﹤0.01%	3079
2014 Q1	$564K	Buy	+30,451	New	+$564K	﹤0.01%	3521